The 2nd Microbiome/Microbiota R&D and Business Collaberation Forum - USA

The field of metagenomics has allowed researchers to delve into the diversity of the body’s microbiota with findings that the microbiome is a home for diversity, natural immunity, metabolism, behavioural traits, and plays an instrumental role in health and disease. With large-scale collaborative projects underway and sequencing data placed in the public domain, there is a rich source of information for researchers and companies looking for opportunities in this exciting field. With increasing signs that our microbiome may be the key not only for curative but preventative medicine, efforts are focusing on increasing both investment opportunities, clinical trials and innovative research in this area. With an increasing focus on healthy living and a therapeutics market that is expected to grow to $1.2 trillion by 2016, microbial research can be developed in order to provide preventative treatments, cures, therapies and supplements for a worldwide audience in demand.

Attracting over 250 attendees, the forum will build upon both our successful American meeting last year and our popular sister European meeting to explore the interface between our evolving cultures, technologies and our microbiome through a series of interactive presentations with leading academics and industry experts, panel discussions and an exhibition area allowing solution providers to showcase their products and services. The latest academic and industry research will explore the human microbiome across the following areas:

Characterising the Human Microbiome
Venture Capital, Collaboration and Investment
The Human Microbiome in Health and Disease
New Research in Microbiology Sites – GI Tract and Outside the Gut
Microbiome and the Food World/Probiotics

The agenda for 2014 is in development. For a more detailed synopsis please visit the Agenda page or download the conference agenda when it become available later in the Spring.